Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.30 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.30 |
| ▸ | CHRNG | P07510 | 3/20 | 0.30 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.30 |
| ▸ | CHRND | Q07001 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11525280 | 1.00 | KDM1A (0.38) | KDM1AMAOBADH1BADH1ACA12 | |
| SCHEMBL27381972 | 1.00 | KDM1A (0.38) | KDM1AMAOBADH1BADH1ACA12 | |
| SCHEMBL17458 | 1.00 | — | — | |
| SCHEMBL530404 | 1.00 | KDM1A (0.38) | KDM1AMAOBADH1BADH1ACA12 | |
| Hydrochloric Acid SCHEMBL932936 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL8648521 | 0.96 | KDM1A (0.37) | KDM1AMAOBADH1BADH1ACA12 | |
| Methane SCHEMBL27788609 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL8648518 | 0.96 | KDM1A (0.37) | KDM1AMAOBADH1BADH1ACA12 | |
| Hydrochloric Acid SCHEMBL8308713 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL4166670 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 833 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842178-A | Resin composition and preparation method and application thereof | 上海玟昕科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| WO-2024056688-A1 | METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE | ARKEMA FRANCE (FR) | 2024-03-21 | — | — | WO | claimed |
| CN-117479963-A | PEG lipids and lipid nanoparticles | 盖纳万科学有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-112430323-B | Transparent polyimide film with excellent performance and preparation method thereof | 深圳瑞华泰薄膜科技股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-112430323-A | Transparent polyimide film with excellent performance and preparation method thereof | 深圳瑞华泰薄膜科技股份有限公司 | 2021-03-02 | — | — | CN | claimed |
| EP-2016038-B1 | RECOVERY OF AROMATIC DICARBOXYLIC ACIDS FROM WASTE POLYESTER RESIN IN THE PRESENCE OF A POLYAMIDE | COBARR S R L (IT) | 2009-11-11 | — | — | EP | claimed |
| US-5447794-A | Blends of polyamides such as polyhexamethylene adipamide, polycaprolactam and copolymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-09-05 | — | — | US | claimed |
| EP-0227043-A2 | Composite semipermeable membrane and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-07-01 | — | — | EP | claimed |
| US-4398012-A | Transparent copolyamide from caprolactam, cyclic diamine and cyclic dicarboxylic acid | ALLIED CORPORATION (US) | 1983-08-09 | — | — | US | claimed |
| US-4036906-A | NONHYDROLYZING | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-07-19 | — | — | US | claimed |
| US-3944552-A | VULCANIZATION | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-03-16 | — | — | US | claimed |
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-3886904-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12559631-B2 | Thermally curable two-component coating compounds | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20250333609-A1 | HYDROPHILIC COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-30 | — | — | US | disclosed |
| US-4022833-A | ANTIBACTERIAL AGENTS | STERLING DRUG INC. (US) | 1977-05-10 | — | — | US | disclosed |
| US-4017325-A | Pigment composition | HULL-SMITH CHEMICALS, INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-3962511-A | Textile composite structure and method of preparation | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3950590-A | POLYETHERURETHANE COATING | CELANESE CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
| US-3944552-A | VULCANIZATION | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | KDM1A 329/4885MAOB 2150/4885ADH1B 1608/4885 |
| US-12559631-B2 | Thermally curable two-component coating compounds | ESD, MGMT, MTHFD2 | KDM1A 1704/4885MAOB 1890/4885ADH1B 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.